NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055391

Registered date:15/11/2024

Evaluation of a Novel Approach for Reducing Psychological Stress in Terminal Cancer Patients Using MR/VR Environments

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedMalignant Tumor
Date of first enrollment2024/11/15
Target sample size20
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe effectiveness of regularly experiencing MR and VR will be evaluated by measuring patients' perceived pain and anxiety using scoring methods such as ESAS (Edmonton Symptom Assessment System) and HADS (Hospital Anxiety and Depression Scale), along with GSR (Galvanic Skin Response) to assess physiological stress responses.
Secondary OutcomeComprehensive analysis of changes in blood miRNA due to regular MR and VR experiences will be conducted to explore new biomarkers for objectively measuring stress.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. The attending physician has determined that the patient is ineligible for participation in the study.

Related Information

Contact

public contact
Name Takeshi Nagasaka
Address 577, Matsushima, Kurashiki-city, Okayama Japan 7010192
Telephone 0864621111
E-mail takeshin@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School Advanced Oncology
scientific contact
Name Takeshi Nagasaka
Address 577, Matsushima, Kurashiki-city, Okayama Japan
Telephone 0864621111
E-mail takeshin@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School Advanced Oncology